» Articles » PMID: 33732989

Spectrum of Kidney Involvement in Patients with Myelodysplastic Syndromes

Abstract

Introduction: Myelodysplastic syndromes (MDS) are characterized by a high prevalence of associated autoimmune manifestations. Kidney involvement has been rarely reported in MDS patients. We report on the spectrum of kidney pathological findings in MDS patients.

Methods: We retrospectively identified MDS patients who had undergone a kidney biopsy between 2001 and 2019 in nine Swiss and French nephrology centres.

Results: Nineteen patients (median age 74 years [63-83]) were included. At the time of kidney biopsy, eleven (58%) patients had extra-renal auto-immune manifestations and sixteen (84%) presented with acute kidney injury. Median serum creatinine at diagnosis was 2.8 mg/dL [0.6-8.3] and median urinary protein to creatinine ratio was 1.2 g/g [0.2-11]. Acute tubulo-interstitial nephritis (TIN) was present in seven (37%) patients. Immunofluorescence study in one patient with acute TIN disclosed intense IgG deposits along the tubular basement membrane and Bowman's capsule. Other kidney pathological features included ANCA-negative pauci-immune necrotizing and crescentic glomerulonephritis (n = 3), membranous nephropathy (n = 2), IgA nephropathy (n = 1), IgA vasculitis (n = 1), immunoglobulin-associated membrano-proliferative glomerulonephritis type I (n=1), crescentic C3 glomerulopathy (n = 1), fibrillary glomerulonephritis (n = 1) and minimal change disease (n = 1). Eleven (58%) patients received immunosuppressive treatments, among whom one developed a severe infectious complication. After a median follow-up of 7 month [1-96], nine (47%) patients had chronic kidney disease stage 3 (n = 6) or 4 (n = 3) and five (26%) progressed to end-stage kidney disease. Three patients died.

Conclusions: MDS are associated to several autoimmune kidney manifestations, predominantly acute TIN. MDS are to be listed among the potential causes of autoimmune TIN.

Citing Articles

Kidney involvement in myelodysplastic syndromes.

Lafargue M, Duong van Huyen J, Rennke H, Essig M, Bobot M, Jourde-Chiche N Clin Kidney J. 2024; 17(8):sfae185.

PMID: 39099564 PMC: 11292217. DOI: 10.1093/ckj/sfae185.


Immune Complex Glomerulonephritis in a Patient with Myelodysplastic Syndrome with Ring Sideroblasts Treated with Luspatercept.

Delanghe S, Nguyen T, Mazure D, Dendooven A, Speeckaert M Diagnostics (Basel). 2023; 13(1).

PMID: 36611303 PMC: 9818993. DOI: 10.3390/diagnostics13010011.


Renal Diseases Associated with Hematologic Malignancies and Thymoma in the Absence of Renal Monoclonal Immunoglobulin Deposits.

Morel A, Meuleman M, Moktefi A, Audard V Diagnostics (Basel). 2021; 11(4).

PMID: 33921123 PMC: 8071536. DOI: 10.3390/diagnostics11040710.

References
1.
Paydas S, Tuncer I, Zorludemir S, Gonlusen G . A case with membranous glomerulonephritis and myelodysplastic syndrome. Nephron. 1992; 62(2):231-2. DOI: 10.1159/000187040. View

2.
Rahimian S, Johnson T, Herb R . A Case of Essential Thrombocythemia and IgA Nephropathy with Literature Review of the Concurrence. Case Rep Oncol Med. 2019; 2019:5086963. PMC: 6745099. DOI: 10.1155/2019/5086963. View

3.
Saif M, Hopkins J, Gore S . Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Lymphoma. 2003; 43(11):2083-92. DOI: 10.1080/1042819021000016186. View

4.
Apostolou T, Sotsiou F, Pappas C, Rontoianni D, Apostolidis J, Nikolopoulou N . Atheroembolic renal disease and membranous nephropathy, in a patient with myelodysplastic syndrome, eosinophilia, and trisomy 8. Nephrol Dial Transplant. 2002; 17(7):1336-8. DOI: 10.1093/ndt/17.7.1336. View

5.
Patnaik M, Tefferi A . Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management. Am J Hematol. 2018; 93(6):824-840. PMC: 5995129. DOI: 10.1002/ajh.25104. View